The result was announced after market hours on Friday, 24 May 2013.
Meanwhile, the S&P BSE Sensex was up 172 points, or 0.87%, to 19,876.33.
On BSE, 56,000 shares were traded in the counter as against an average daily volume of 20,358 shares in the past one quarter.
The stock hit a high of Rs 86.80 and a low of Rs 83.30 so far during the day. The stock had hit a 52-week high of Rs 96.40 on 26 December 2012. The stock had hit a 52-week low of Rs 59 on 25 May 2012.
The stock had outperformed the market over the past one month till 24 May 2013, rising 3.31% compared with the Sensex's 2.74% rise. The scrip had, however, underperformed the market in past one quarter, rising 0.30% as against Sensex's 2.01% rise.
The small-cap company has an equity capital of Rs 16.94 crore. Face value per share is Rs 2.
J B Chemicals & Pharmaceuticals' (JBCPL) net profit declined 86.78% to Rs 84.94 crore on 24.96% rise in net sales to Rs 794.46 crore in the year ended March 2013 over the year ended March 2012.
The financial results for the year ended on 31 March 2013 are strictly not comparable with the results of the previous year due to sale of Russia-CIS OTC business during the previous year. However, the quarterly results are comparable, the company said in a statement.
The board of JBCPL has recommended a dividend of Rs 3 per equity share.
JBCPL, one of India's leading pharmaceutical companies, manufactures & markets a diverse range of pharmaceutical formulations, herbal remedies and API's. JBCPL exports to many countries worldwide with a strong presence in Russia, Ukraine, CIS countries and South Africa. The company continues to invest in growing its share in the regulated markets in USA, Europe, Australia and Brazil.
Powered by Capital Market - Live News
